The role of IOP in glaucoma

Article

The World Glaucoma Association has announced consensus findings that further determine the role of intraocular pressure (IOP) in glaucoma.

The World Glaucoma Association has announced consensus findings that further determine the role of intraocular pressure (IOP) in glaucoma.

A total of seven consensus points were evaluated to help determine how IOP should be measured and used, in order to better understand its overall role in glaucoma: determinants of IOP, measurement of IOP, IOP variation, epidemiology of IOP, IOP as a risk factor for glaucoma development and progression, clinical trials and IOP and target IOP in clinical practice.

The panel stressed that IOP should be evaluated on an individual basis and that target IOPs should be defined as the estimated range where the risk of progressive disease is unlikely to affect the patient's quality of life. The panel also discussed ways to measure IOP more accurately and the measurement of central corneal thickness was identified as a crucial aspect of this.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.